Effect of supportive-expressive therapy on fear of progression and resilience in lymphoma patients
10.3760/cma.j.cn211501-20210421-01188
- VernacularTitle:支持性表达疗法对淋巴瘤患者恐惧疾病进展和心理韧性的影响
- Author:
Yan HU
1
;
Xiaoqian ZHAO
;
Lei FAN
Author Information
1. 南京医科大学第一附属医院血液科，南京 210029
- Keywords:
Lymphoma;
Supportive-expressive therapy;
Fear of progression;
Resilience
- From:
Chinese Journal of Practical Nursing
2022;38(17):1287-1291
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the effect of supportive-expressive therapy (SET) on fear of progression and resilience in lymphoma patients, to provide reference for clinical nursing care.Methods:A total of 86 patients with lymphoma treated in the First Affiliated Hospital of Nanjing Medical University from February 2019 to September 2020 were divided into experimental group and control group according to random number table method, with 43 cases in each group. The control group was given conventional nursing, while the experimental group was applied with 6 times SET. Before and after intervention, the Fear of Progression Questionnaire-Short Form (FoP-Q-SF) and Connor Davidson Resilience Scale (CD-RISC) was evaluated between two groups.Results:Finally, 40 cases were included in the experimental group and 42 cases in the control group. There was no significant difference between each dimension and total score of the two groups before intervention ( P>0.05). After intervention, scores of physiological health dimension, social and family dimension, and total FoP-Q-SF were (14.90 ± 3.96) points, (15.03 ± 4.29) points and (29.93 ± 5.65) points in the experimental group, significantly lower than those in the control group (17.71 ± 3.38) points, (17.29 ± 4.03) points and (35.00 ± 5.57) points ( t=3.47, 2.46, 4.10, all P<0.05); scores of tenacity, strength, optimism dimension and total CD-RISC were (28.08 ± 4.47) points, (21.30 ± 5.58) points, (10.65 ± 2.97) points and (60.03 ± 8.42) points in the experimental group, significantly higher than those in the control group (24.31 ± 4.11) points, (17.98 ± 4.13) points, (9.26 ± 2.47) points and (51.55 ± 5.86) points, the differences were statistically significant ( t values were 2.30-5.27, all P<0.05). Conclusions:SET can effectively alleviate the degree of fear of progression and promote resilience of lymphoma patients.
